quinapril has been researched along with Arteriosclerosis in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aragoncillo, P; Cachofeiro, V; Cediel, E; de las Heras, N; Díaz, C; Hernández, G; Lahera, V; Oubiña, MP; Sanz-Rosa, D | 1 |
Carvalho, AC; de Paola, AA; Fonseca, FA; Ihara, SS; Izar, MC; Kasinski, N; Lopes, IE; Paiva, TB; Pinto, LE; Silva, EP; Tufik, S | 1 |
Casarini, DE; Ebihara, F; Fonseca, FA; Ihara, SS; Izar, MC; Pinto, LE; Pomaro, DR; Santos, AO; Ueda, I | 1 |
Kiemeney, LA; Meuleman, EJ; Smits, P; Speel, TG; Thien, T | 1 |
Bustos, C; Egido, J; Hernández-Presa, M; Ortego, M; Renedo, G; Ruiz-Ortega, M; Tuñon, J | 1 |
Dai, E; Liu, LY; Lucas, A; Nation, PN | 1 |
Pepine, C | 1 |
Bustos, C; Egido, J; Hernández-Presa, MA; Ortega, L; Ortego, M; Tuñón, J | 1 |
Di Veroli, C; Gazzaniga, PP; Lenti, L; Marigliano, V; Pignatelli, P; Pulcinelli, FM; Riondino, S | 1 |
Browne, AE; Chatterjee, K; Chou, TM; Deedwania, PC; Glantz, SA; Parmley, WW; Pulukurthy, S; Sudhir, K; Sun, YP; Zhu, BQ | 1 |
2 trial(s) available for quinapril and Arteriosclerosis
Article | Year |
---|---|
Long-term effect of inhibition of the angiotensin-converting enzyme (ACE) on cavernosal perfusion in men with atherosclerotic erectile dysfunction: a pilot study.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Penis; Pilot Projects; Quinapril; Severity of Illness Index; Tetrahydroisoquinolines; Treatment Outcome | 2005 |
Angiotensin-converting enzyme inhibitors in patients with atherosclerosis and preserved left ventricular function: clinical outcomes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Coronary Disease; Endothelium, Vascular; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines; Ventricular Function, Left | 1998 |
8 other study(ies) available for quinapril and Arteriosclerosis
Article | Year |
---|---|
Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits.
Topics: Acyl Coenzyme A; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arteriosclerosis; Atorvastatin; Blood Pressure; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Fibrinolysis; Heptanoic Acids; Hypercholesterolemia; In Vitro Techniques; Inflammation Mediators; Male; Pyrroles; Quinapril; Rabbits; Tetrahydroisoquinolines; Tunica Intima; Vasodilation | 2003 |
Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Drug Interactions; Hydrochlorothiazide; In Vitro Techniques; Male; Quinapril; Rabbits; Tetrahydroisoquinolines; Vasodilation | 2003 |
High glucose levels abolish antiatherosclerotic benefits of ACE inhibition in alloxan-induced diabetes in rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Glucose; Diabetes Mellitus, Experimental; Hypercholesterolemia; Male; Quinapril; Rabbits; Tetrahydroisoquinolines | 2005 |
Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Cell Movement; Cells, Cultured; Chemokine CCL2; Femoral Artery; Gene Expression; Immunohistochemistry; Isoquinolines; Macrophages; Male; Monocytes; Muscle, Smooth, Vascular; NF-kappa B; Peptidyl-Dipeptidase A; Quinapril; Rabbits; Tetrahydroisoquinolines | 1997 |
Atherosclerosis in Marek's disease virus infected hypercholesterolemic roosters is reduced by HMGCoA reductase and ACE inhibitor therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Carotid Arteries; Chickens; Cholesterol; Disease Models, Animal; Herpesvirus 2, Gallid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Isoquinolines; Lymphocytes; Marek Disease; Pravastatin; Quinapril; Tetrahydroisoquinolines | 1998 |
ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Arteriosclerosis; Chemokine CCL2; Cholesterol; Collagen; Disease Models, Animal; Immunohistochemistry; In Situ Hybridization; Interleukin-8; Isoquinolines; Macrophages; NF-kappa B; Platelet-Derived Growth Factor; Quinapril; Rabbits; Tetrahydroisoquinolines | 1998 |
Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; Endothelin-1; Female; Humans; Hypertension; Interleukin-1; Interleukin-6; Isoquinolines; Male; Nifedipine; P-Selectin; Platelet Activation; Platelet Aggregation; Prevalence; Prodrugs; Quinapril; Tetrahydroisoquinolines | 1999 |
Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteriosclerosis; Captopril; Cholesterol; Disease Models, Animal; Isoquinolines; Kinins; Losartan; Male; Nitric Oxide; Quinapril; Rabbits; Receptors, Angiotensin; Tetrahydroisoquinolines; Vasoconstriction; Vasodilation | 2001 |